Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042537
Filing Date
2019-11-12
Accepted
2019-11-12 07:19:03
Documents
68
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-10q_20190930.htm 10-Q 2045601
2 EX-31.1 vcnx-ex311_194.htm EX-31.1 21317
3 EX-31.2 vcnx-ex312_193.htm EX-31.2 21223
4 EX-32.1 vcnx-ex321_192.htm EX-32.1 11181
  Complete submission text file 0001564590-19-042537.txt   5969472

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vcnx-20190930.xml EX-101.INS 1035764
6 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20190930.xsd EX-101.SCH 49370
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vcnx-20190930_cal.xml EX-101.CAL 38697
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcnx-20190930_def.xml EX-101.DEF 153645
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20190930_lab.xml EX-101.LAB 367271
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20190930_pre.xml EX-101.PRE 290080
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 191206064
SIC: 2834 Pharmaceutical Preparations